Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Single-cell engineered biotherapeutics show promise for skin treatment but need more research and trials.

AGA patients have higher rates of metabolic syndrome and carotid atheromatosis, suggesting early screening and prevention is important.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

Enobosarm significantly increased muscle mass and improved physical function in elderly men and postmenopausal women without serious side effects.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Germany recognizes skin cancer from UV exposure as an occupational disease, emphasizing prevention and care for affected workers.

The conclusion is that there is a high demand for new contraceptives that provide both pregnancy prevention and protection against STIs, along with additional health benefits.

The document suggests a young mother use effective contraception like the Copper-T IUD while considering her health and the need for STD prevention.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

Spironolactone improved cognitive performance and early sleep quality but not manic symptoms, appetite, or body weight in bipolar disorder when added to sodium valproate.

The document concludes that identifying the specific cells where skin cancers begin is important for creating better prevention, detection, and treatment methods.

The book provides detailed information on natural ingredients in beauty products and emphasizes the need for more human trials to confirm their effectiveness.

Using minoxidil with laser therapy is more effective for female hair loss than minoxidil alone.

Older men with scalp wounds had long-term healing problems after using imiquimod or diclofenac for skin cancer prevention.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

New topical antifungals and delivery systems are improving treatment for fungal skin infections, but patient education and prevention are key.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Peginterferon alfa-2b and ribavirin therapy for hepatitis C can cause serious side effects, some different from those reported in clinical trials.

Spironolactone, a heart and liver drug, has new uses including cancer treatment, viral infection prevention, and skin condition improvement.

A common cause of skin infections in the U.S. is a strain of bacteria resistant to certain antibiotics, and prevention focuses on cleanliness and avoiding close contact.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Miracle fruit seed oil significantly reduces hair breakage in women with damaged hair.

Some skin conditions may increase the risk of heart disease, but are not yet included in cardiovascular prevention guidelines.

IVL3001 is safe, effective, and better than oral finasteride for treating hair loss.

Using fractional CO2 laser with halometasone cream works better for chronic hand eczema than just the cream, improving symptoms and quality of life with fewer relapses.

In June 2019, the stem cell research field saw major progress, including new clinical trials, FDA approvals, and industry collaborations.